![Stephan Jenn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Stephan Jenn
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
NovAliX SAS
![]() NovAliX SAS BiotechnologyHealth Technology NovAliX SAS operates as a drug discovery-focused contract research organization. It offers drug discovery services in the fields of chemistry, collaborative models, biophysics and biology. The company was founded by Stephan Jenn and Jean-Paul Renaud in 2002 and is headquartered in Illkirch, France.
2
| Holding Company | Biotechnology | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stephan Jenn
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Urania Therapeutics SAS
![]() Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Director/Board Member Founder |
Statistik
International
Frankreich | 2 |
Sektoral
Health Technology | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Founder | 2 |
Chief Executive Officer | 1 |
President | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Denis Zeyer | 2 |
Jean-Paul Renaud | 2 |
- Börse
- Insiders
- Stephan Jenn
- Unternehmensverbindungen